Els M.J.J. Berns

9.1k total citations · 1 hit paper
87 papers, 6.3k citations indexed

About

Els M.J.J. Berns is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Els M.J.J. Berns has authored 87 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 35 papers in Oncology and 32 papers in Genetics. Recurrent topics in Els M.J.J. Berns's work include Estrogen and related hormone effects (25 papers), Cancer Genomics and Diagnostics (16 papers) and Ovarian cancer diagnosis and treatment (15 papers). Els M.J.J. Berns is often cited by papers focused on Estrogen and related hormone effects (25 papers), Cancer Genomics and Diagnostics (16 papers) and Ovarian cancer diagnosis and treatment (15 papers). Els M.J.J. Berns collaborates with scholars based in Netherlands, Belgium and United States. Els M.J.J. Berns's co-authors include John A. Foekens, Jan G.M. Klijn, Maxime P. Look, Marion E. Meijer‐van Gelder, Anieta M. Sieuwerts, Mieke Timmermans, Iris L. van Staveren, Jack X. Yu, Yixin Wang and Yi Zhang and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Els M.J.J. Berns

86 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

2005 2.1k citations Jan G.M. Klijn, Anieta M. Sieuwerts et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Els M.J.J. Berns Netherlands	40	3.9k	2.4k	2.3k	1.1k	671	87	6.3k
Amir A. Jazaeri United States	34	2.6k 0.7×	2.3k 1.0×	1.8k 0.8×	858 0.7×	504 0.8×	169	5.7k
Elena López‐Knowles United Kingdom	24	4.6k 1.2×	4.3k 1.8×	2.1k 0.9×	1.3k 1.2×	1.2k 1.8×	46	7.3k
Lori S. Friedman United States	42	4.8k 1.2×	2.5k 1.1×	1.1k 0.5×	1.9k 1.7×	762 1.1×	106	7.4k
Constance T. Albarracin United States	43	1.8k 0.5×	1.7k 0.7×	2.1k 0.9×	894 0.8×	851 1.3×	122	5.2k
Joshy George United States	34	4.3k 1.1×	2.2k 0.9×	2.0k 0.9×	995 0.9×	540 0.8×	65	7.4k
Ian Hickson United Kingdom	16	4.8k 1.2×	4.2k 1.8×	1.0k 0.4×	996 0.9×	571 0.9×	28	6.4k
Maxime P. Look Netherlands	49	5.9k 1.5×	3.6k 1.5×	4.5k 1.9×	1.2k 1.1×	921 1.4×	115	10.0k
Marion E. Meijer‐van Gelder Netherlands	37	3.9k 1.0×	2.4k 1.0×	2.7k 1.2×	1.1k 0.9×	568 0.8×	61	6.4k
Yinhua Yu United States	42	3.8k 1.0×	1.2k 0.5×	1.1k 0.5×	790 0.7×	292 0.4×	82	5.8k
Aurelia Noske Germany	38	3.2k 0.8×	3.2k 1.3×	1.9k 0.8×	385 0.3×	705 1.1×	102	6.8k

Countries citing papers authored by Els M.J.J. Berns

Since Specialization

Citations

This map shows the geographic impact of Els M.J.J. Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els M.J.J. Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els M.J.J. Berns more than expected).

Fields of papers citing papers by Els M.J.J. Berns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els M.J.J. Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els M.J.J. Berns. The network helps show where Els M.J.J. Berns may publish in the future.

Co-authorship network of co-authors of Els M.J.J. Berns

This figure shows the co-authorship network connecting the top 25 collaborators of Els M.J.J. Berns. A scholar is included among the top collaborators of Els M.J.J. Berns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els M.J.J. Berns. Els M.J.J. Berns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeannot, Emmanuelle, Aurélien Latouche, Claire Bonneau, et al.. (2022). 2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse. International Journal of Gynecological Cancer. 32. A404–A404. 1 indexed citations

Prassas, Ioannis, et al.. (2017). Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation. Clinical Chemistry and Laboratory Medicine (CCLM). 55(9). 1291–1304. 8 indexed citations

Leonard, Brandon, Gabriel J. Starrett, Matthew J. Maurer, et al.. (2016). APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma. Clinical Cancer Research. 22(18). 4746–4755. 52 indexed citations

Samuels, Sanne, Balázs Bálint, Heiko von der Leyen, et al.. (2016). Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study. British Journal of Cancer. 115(12). 1575–1583. 6 indexed citations

Beelen, Karin, Mark Opdam, Tesa Severson, et al.. (2014). PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients. Breast Cancer Research. 16(1). R13–R13. 46 indexed citations

Helmijr, Jean, Maxime P. Look, Irene Lurkin, et al.. (2013). Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen. Breast Cancer Research and Treatment. 139(1). 39–49. 43 indexed citations

Jansen, Maurice P.H.M., Theo Knijnenburg, Iris Simón, et al.. (2013). Hallmarks of Aromatase Inhibitor Drug Resistance Revealed by Epigenetic Profiling in Breast Cancer. Cancer Research. 73(22). 6632–6641. 57 indexed citations

Scholl, Suzy, Maud Kamal, Leanne de Koning, et al.. (2013). HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies. Current Pharmaceutical Design. 19(8). 1379–1394. 1 indexed citations

Riaz, Muhammad, Els M.J.J. Berns, Anieta M. Sieuwerts, et al.. (2011). Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Research and Treatment. 133(3). 843–851. 46 indexed citations

10.

Helleman, Jozien, Marcel Smid, Maurice P.H.M. Jansen, M. van der Burg, & Els M.J.J. Berns. (2010). Abstract 411: Pathway analysis of gene-lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.. Cancer Research. 70(8_Supplement). 411–411. 1 indexed citations

11.

Ruiter, Rikje, Monique J. Bijl, Ron HN van Schaik, et al.. (2010). CYP2C19*2Polymorphism is Associated with Increased Survival in Breast Cancer Patients Using Tamoxifen. Pharmacogenomics. 11(10). 1367–1375. 44 indexed citations

12.

Kuijper, Arno, Antoine M. Snijders, Els M.J.J. Berns, et al.. (2009). Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.. SHILAP Revista de lepidopterología. 31(1). 31–9. 16 indexed citations

13.

Helleman, Jozien, Maurice P.H.M. Jansen, Kirsten Ruigrok-Ritstier, et al.. (2008). Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response. Clinical Cancer Research. 14(17). 5555–5564. 142 indexed citations

14.

Loi, Sherene, Benjamin Haibe‐Kains, Christine Desmedt, et al.. (2008). Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics. 9(1). 239–239. 281 indexed citations

15.

Helleman, Jozien, Iris L. van Staveren, Winand N.M. Dinjens, et al.. (2006). Mismatch repair and treatment resistance in ovarian cancer. BMC Cancer. 6(1). 201–201. 71 indexed citations

16.

Piersma, Djura, Miriam Verhoef‐Post, Els M.J.J. Berns, & Axel P. N. Themmen. (2006). LH receptor gene mutations and polymorphisms: An overview. Molecular and Cellular Endocrinology. 260-262. 282–286. 34 indexed citations

17.

Dorssers, Lambert C. J., S. van der Flier, Arend Brinkman, et al.. (2001). Tamoxifen Resistance in Breast Cancer. Drugs. 61(12). 1721–1733. 77 indexed citations

18.

Henzen‐Logmans, Sonja C., John A. Foekens, Els M.J.J. Berns, et al.. (1993). The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study. European Journal of Cancer. 29(14). 1951–1957. 33 indexed citations

19.

Berns, Els M.J.J., et al.. (1992). Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptors. European Journal of Cancer. 28(2-3). 697–700. 97 indexed citations

20.

Berns, Els M.J.J., et al.. (1992). Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer. International Journal of Cancer. 52(2). 218–224. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact